Status:
COMPLETED
Comparison of Three Management Strategies for Post Cardiac Surgery Bleeding
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Anemia Institute for Research & Education
Conditions:
Heart Disease
Coagulopathy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Open-heart surgery frequently results in abnormal clotting, which in turn results in excessive blood loss and the need for transfusion of multiple blood products to patients and leads to adverse outco...
Eligibility Criteria
Inclusion
- greater than 18 years
- no emergent complex cardiac surgery
Exclusion
- Isolated CABG
- Single valve surgery
- Pre-existing coagulopathy PTT\>50's, INR\>1.3
- Severe Thrombocytopenia Platelet \<100,000
- Recent Antiplatelet drugs(Plavix within 7 days, Integrilin within 24 hours)
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00188747
Start Date
June 1 2005
Last Update
October 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital, University Health Network
Toronto, Ontario, Canada, M5G 2C4